Literature DB >> 32675840

PREVENTIVE CARDIOLOGY AS NEW SUBSPECIALTY OF CARDIOVASCULAR MEDICINE.

Sergio Fazio1, Michael D Shapiro1.   

Abstract

Although management of ischemic cardiovascular disease has improved by leaps and bounds and significantly reduced the risk of mortality from a heart attack relative to decades past, the life trajectory of the average person (with stress, poor diet, excess body weight, inactivity, smoking, exposure to pollutants, poor management of metabolic comorbidities, etc.) still leads straight to development of this disease. Therefore, we have an unprecedented opportunity to focus on prevention of atherosclerosis before cardiovascular events occur, an endeavor that needs expert intervention with cardiovascular risk assessment, risk factor management, lifestyle counseling, dietary interventions, use of natural supplements, and pharmacotherapy. It is time for the budding specialty of preventive cardiology to come to the fore, from the historic background of fragmented clinical services such as lipid, hypertension, diabetes, endocrine, and cardiology clinics. Many patients need this specialized service, which cannot be provided anywhere else but in a dedicated practice well integrated with all other hospital services. Here we discuss the origin of preventive cardiology, the organization and core competencies required for excellence in this medical art, and the structure for education and fellowship training for professional recognition and board certification.
© 2020 The American Clinical and Climatological Association.

Entities:  

Keywords:  CVD risk assessment; PCSK9; Preventive cardiology; atherosclerotic cardiovascular disease (ASCVD); diabetes; hypercholesterolemia; hypertension; lipid clinic; lipid-lowering agents; medical subspecialty; statins

Year:  2020        PMID: 32675840      PMCID: PMC7358492     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  22 in total

1.  Coronary heart disease in the Framingham study.

Authors:  T R DAWBER; F E MOORE; G V MANN
Journal:  Am J Public Health Nations Health       Date:  1957-04

2.  Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Paul Muntner; Alvaro Alonso; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Sandeep R Das; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Lori Chaffin Jordan; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Martin O'Flaherty; Ambarish Pandey; Amanda M Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Connie W Tsao; Mintu P Turakhia; Lisa B VanWagner; John T Wilkins; Sally S Wong; Salim S Virani
Journal:  Circulation       Date:  2019-03-05       Impact factor: 29.690

Review 3.  Setting the Agenda for Preventive Cardiology.

Authors:  Michael D Shapiro; Sergio Fazio
Journal:  Circ Res       Date:  2017-07-21       Impact factor: 17.367

Review 4.  Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives.

Authors:  Michael D Shapiro; David J Maron; Pamela B Morris; Mikhail Kosiborod; Pratik B Sandesara; Salim S Virani; Amit Khera; Christie M Ballantyne; Seth J Baum; Laurence S Sperling; Deepak L Bhatt; Sergio Fazio
Journal:  J Am Coll Cardiol       Date:  2019-10-15       Impact factor: 24.094

5.  The Role of the Clinical Pharmacist in a Preventive Cardiology Practice.

Authors:  Bruce A Warden; Michael D Shapiro; Sergio Fazio
Journal:  Ann Pharmacother       Date:  2019-07-25       Impact factor: 3.154

6.  The prevalence of obesity documentation in Primary Care Electronic Medical Records. Are we acknowledging the problem?

Authors:  Ahmed Mattar; David Carlston; Glen Sariol; Tongle Yu; Ahmad Almustafa; Genevieve B Melton; Adil Ahmed
Journal:  Appl Clin Inform       Date:  2017-01-25       Impact factor: 2.342

7.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

8.  Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review.

Authors:  Melissa Snider; Steven Kalbfleisch; Cynthia A Carnes
Journal:  Clin Ther       Date:  2009-06       Impact factor: 3.393

9.  Lipids and risk of coronary heart disease. The Framingham Study.

Authors:  W P Castelli; K Anderson; P W Wilson; D Levy
Journal:  Ann Epidemiol       Date:  1992 Jan-Mar       Impact factor: 3.797

10.  Coronary heart disease morbidity and mortality in hypercholesterolemic men predicted from an exercise test: the Lipid Research Clinics Coronary Primary Prevention Trial.

Authors:  L G Ekelund; C M Suchindran; R P McMahon; G Heiss; A S Leon; D W Romhilt; C L Rubenstein; J L Probstfield; J F Ruwitch
Journal:  J Am Coll Cardiol       Date:  1989-09       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.